Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06998264

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
2 Years – 5 Years
Healthy volunteers
Not accepted

Summary

The NoseFlu-Kids project aims at characterizing the immune response in the upper respiratory tract in children aged 2 to 5 with a laboratory-confirmed influenza infection. The immune response during the acute phase of the infection and after recovery will be compared to that of control children with no infection or vaccinated with the inactivated flu vaccine by the nasal route (recruited as part of a mirror study in Oxford). The primary objective of this observational study is to quantify the inflammatory response in the nasal cavity and to correlate it with viral load and with clinical parameters. The study also aims to compare the inflammatory response measured in the nose to that measured in the blood. Participants will have two study visits including a blood draw, several nasal samplings (nasal lining fluid and nasal cells) and a saliva sampling, one within 72 hours of their hospital admission and another one month later. Nasal lining fluid and saliva will be obtained every two or three days until symptoms disappear. During those visits, questions regarding symptoms will be asked.

Conditions

Timeline

Start date
2025-03-04
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2025-05-31
Last updated
2025-05-31

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06998264. Inclusion in this directory is not an endorsement.